Author:
Schiemann M.,Depka Prondzinski M.,Stoll H.,Scharrer I.
Publisher
Springer Berlin Heidelberg
Reference28 articles.
1. Alessi MC, Juhan-Vague I, Declerck PJ, Collen D (1991) Molecular forms of Plasminogen activator inhibitor-1 (PAI-1) and tissue-type Plasminogen activator (t-PA) in human plasma. Thromb Res 62:275–285
2. Bazaan M, Tamponi G, Stella S, Schinco PC, Pannocchia A, Pileri A (1993) Fibrinolytic imbalance in Essential Thrombocythemia: role of platelets. Haemostasis 23:138–44
3. Bellucci S, Ignatova E, Jaillet N, Boffa MC (1993) Platelet hyperactivation in patients with Essential Thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of Plasma Thrombomodulin, Protein S, PAI-1, t-PA und vWF. Thromb Haemost 70,5:736–742
4. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR (1988) Plasminogen activator inhibitor (PAI-i) in plasma and platelets. Br J Haematol 70:327–333
5. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJF (1993) Circadian Variation of tissue Plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Br Heart J 69:121–124